Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model

被引：0
|
作者：
Lisa Ferguson-Sells
Nieves Velez de Mendizabal
Baohui Li
David Small
机构：
[1] Eli Lilly and Company,
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：249 / 262
页数：13
相关论文
共 50 条
  • [1] Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model
    Ferguson-Sells, Lisa
    de Mendizabal, Nieves Velez
    Li, Baohui
    Small, David
    CLINICAL PHARMACOKINETICS, 2022, 61 (02) : 249 - 262
  • [2] Initial Experience With Tadalafil In Pediatric Pulmonary Arterial Hypertension
    Takatsuki, S.
    Calderbank, M.
    Ivy, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [3] Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension
    Shinichi Takatsuki
    Michelle Calderbank
    David Dunbar Ivy
    Pediatric Cardiology, 2012, 33 : 683 - 688
  • [4] Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Calderbank, Michelle
    Ivy, David Dunbar
    PEDIATRIC CARDIOLOGY, 2012, 33 (05) : 683 - 688
  • [5] POPULATION PHARMACOKINETICS MODEL AND PEDIATRIC DOSE RECOMMENDATION FOR IV SILDENAFIL IN PULMONARY ARTERIAL HYPERTENSION
    Hazra, A.
    Gao, X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S87 - S88
  • [6] Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension
    Axelsen, Lene Nygaard
    Kuemmel, Anne
    Ruixo, Juan Jose Perez
    Russu, Alberto
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (12): : 2185 - 2195
  • [7] Pharmacokinetics and Safety of Ambrisentan in Pediatric Patients with Pulmonary Arterial Hypertension
    Ivy, D.
    Rosenzweig, E. B.
    Calderbank, M.
    Coleman, B.
    Miller-Reed, K.
    Geppner, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [8] Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension
    Willmann, Stefan
    Keller, Andrea Kerstin
    Meyer, Michaela
    van Der Mey, Dorina
    Wirsching, Gabriela
    Zhang, Yang
    Drenth, Henk-Jan
    Keunecke, Anne
    Vendel, Esmee
    Saleh, Soundos
    PEDIATRIC PULMONOLOGY, 2023, 58 (03) : 908 - 917
  • [9] Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    Barst, RJ
    Ivy, D
    Dingemanse, J
    Widlitz, A
    Schmitt, K
    Doran, A
    Bingaman, D
    Nguyen, N
    Gaitonde, M
    van Giersbergen, PLM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) : 372 - 382
  • [10] Population pharmacokinetics of sildenafil in paediatric and adult patients with pulmonary arterial hypertension
    Watt, S.
    Hayashi, N.
    Harnisch, L.
    Gao, X.
    EUROPEAN HEART JOURNAL, 2010, 31 : 762 - 763
12345